Informed consent statement: Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained retrospectively.
INTRODUCTION
Infections are a worldwide problem concerning patients admitted to intensive care units (ICU), since they are associated with an increased mortality, morbidity and financial burden [1] [2] [3] [4] . A 51%-prevalence of infection has been reported for ICU-patients and previously 20% of patients admitted with septic-shock to an ICU received inappropriate antimicrobial-therapy [5] . This knowledge led to increased efforts to implement early-goaldirected therapy with timely initiation of appropriate antimicrobial-therapy in clinical practice [4] . The aim of the present study was to assess the rate of infection, as well as appropriate-and inappropriate antimicrobial-therapy after implementation of earlygoal-directed therapy of infection and sepsis on an Internal-Medicine-ICU and to assess the association of appropriate-and inappropriate antimicrobial-therapy on mortality. In addition, special focus was drawn on the subgroup of patients with liver cirrhosis. This special interest was derived due to the hepatologic focus of our unit with a large hepatology outpatient and innpatient clinic including transplantation unit. A previous meta-analysis reported a 4-fold increase in mortality in patients with liver-cirrhosis that acquire an infection [6] .
MATERIALS AND METHODS
All patients admitted to the Internal-Medicine-ICU of the Goethe-University-Hospital-Frankfurt between April 1, 2007 and December 31, 2009 were included in the study. Data were extracted retrospectively from all patients using patient-charts and electronicdocumentations on infection, microbial-isolates, diagnosis and therapy. The study was approved by the local ethical-committee. The study protocol included the special focus on liver cirrhosis patients and was approve prior to the study recruitment.
Demographic, physiological, antimicrobial and therapeutic-data were collected from all patients. Only the first seven days after ICU-admission were evaluated concerning microbial-isolates and antibioticregimen. Patient characteristics are shown in Tables 1  and 2 .
Infection was defined according to the definitions of the International Sepsis-Forum [7] and adjudicated by the senior-physicians. Data concerning infection were extracted from the ICU-doctor´s final-report, from imaging (Computed-Tomogaphy, Magnetic-ResonanceImaging, X-ray, ultrasound, endoscopy) and from the microbiological laboratory-reports. Appropriate/inappropriate antimicrobial-therapy was determined for all patients with infection. Appropriate initial antimicrobial-therapy was defined as: (1) Initiation of appropriate empirical antimicrobialtherapy at symptom begin (recurrence or persistent hypotension) with in vitro activity appropriate to isolated pathogenic organisms according to the Sanford Guide on Antimicrobial Therapy 2010 (40 th edition) [8] and the national guidelines 2010 of the PaulEhrlich-society for chemotherapy [9] or according to the antibiotic susceptibility-testing; and (2) Appropriate empiric therapy for culture negative infections accor- [8] and national guidelines 2010 of the Paul-Ehrlich-society for chemotherapy and the local hospital resistancestatistics [9] and initiation of appropriate antimicrobialtherapy at symptom begin.
In addition appropriate adjustment of antimicrobialtherapy within the first 7 d of ICU-stay was recorded.
Statistical analysis
The primary statistical-endpoint was the evaluation of the influence of appropriate versus inappropriate antimicrobial-therapy on in-hospital-mortality. Multivariate-logistic regression-analysis was performed. The statistical analysis was performed using SPSSversion-20 (SPSS-Inc, Chicago, IL, United States).
Data were expressed as mean ± SD for normally distributed variables and median and range for others. All statistical tests were 2-sided and p < 0.05 was considered statistically significant. No correction for multiple-testing was done. Wilcoxon-Mann-Whitneytest was used to compare numeric variables between the main-groups of patients. Ordinal-variables were analyzed using Chi-square-test and via binary-logistic regression-analysis. A multivariate-logistic regressionanalysis was performed by forward binary-logisticregression including all relevant nominal-variables, in which the significant variables were selected. of the Goethe-University-Hospital-Frankfurt. From 1979 patients enough data were available to include them into the analysis. Of the 1979 patients, 1042 (53%) were classified as having an infection. Infected patients had more comorbid conditions, higher SAPS-II and TISS-scores, received more often mechanicalventilation and hemodialysis, and had a higher inhospital-mortality-rate than patients without infection. Details are shown in Table 1 .
RESULTS

Characteristics of infection
The most frequent site of infection was the respiratory-tract, followed by gastrointestinal-infections, genitourinary-infections, endocarditis and skin-infections (Table 2) .
In 697 patients (67%) from overall 1042 patients with infection underlying microorganisms were identified. Gram-positive isolates (S. aureos, S. epidermidis, S. pneumoniae, VSE, VRE, and others) were found in 45% (473/1042) of patients with infections and gram-negative isolates (E. coli, Enterobacter spp., Klebsiella spp., Pseudomonas spp., Acinetobacter spp., ESBL-producing Enterobacteriaceae, and others) in 35% (368/1042). Details are shown in Table 2 . Multiresistant-bacteria were present in 23% of patients with infection; these were most frequently vancomycin-resistant Enterococcus faecium (VRE) (8.7%), followed by methicillineresistant Staphylococcus aureus (MRSA) (4.3%) and extended-spectrum-betalactamase (ESBL)-producing enterobacteriaceae (4.0%).
Overall, the rate of survival to hospital-discharge was 66% in patients with infection as compared to 83% of patients without infection (p < 0.000001).
Appropriateness of initial antimicrobial-therapy
From all patients with infection, 91% of patients received appropriate and 9% inappropriate initial antimicrobial-therapy. From the 697 patients with infection and positive blood-culture, 87% received appropriate initial antimicrobial-therapy. The survivalrate to hospital discharge was higher in the group of patients receiving appropriate antimicrobialtherapy (67% vs 57%). However, this difference was not statistically significant (p = 0.054). The rate of inappropriate antimicrobial-therapy in septic-shock was 13.5%. In the group of patients with septic-shock (20% of patients with infection) no significant difference in survival-rate to hospital discharge was found between patients receiving appropriate (n = 179) versus inappropriate (n = 28) initial antimicrobial-therapy (44% vs 36%, p > 0.20). Details are shown in Figure  1 and Table 3 .
Patients who received inappropriate initial antimicrobialtherapy had a longer ICU stay and suffered from higher rates of liver-cirrhosis, HIV, and prior chemotherapy. In addition, patients with multiresistant-bacterial infection received significantly more often inappropriate initial antimicrobial-therapy as compared to patients with other bacterial-infection [58% vs 19%, p < 0.000001; OR = 6.25 (2.59-15.15), p = 0.000046]. Details are shown in Table 3 .
Escalation of antimicrobial-therapy was documented within the first 7 d of ICU stay in 20% of patients with infection, and de-escalation in 31%, respectively. From the 94 patients with infection who received inappropriate initial antimicrobial-therapy, antimicrobialtherapy was adjusted appropriately within the first seven days in 38 (40%) of patients according to the AST.
Mortality
In hospital-mortality-rate was 25% in the overall ICU population and 34% in patients with infection. Details are shown in Table 4 . Multivariate-logistic regression-analysis including all significant variables revealed as independent riskfactors for in hospital-mortality the presence of septicshock at admission [OR = 2.928 (1.246-6.787), p = Risk factors for in-hospital mortality in patients with infection are shown in Table 5 .
Multivariate-logistic regression-analysis for patients with infection only revealed as independent riskfactors for in hospital-mortality the presence of septicshock at admission [OR 
Liver disease
Chronic liver-disease was known in 272 patients (14%) with liver-cirrhosis present in 175 of these patients (64%). From these 272 patients with chronic liver disease, chronic viral hepatitis infection was present in 150 patients (55%), of whom 101 were infected with chronic hepatitis C and 49 with chronic hepatitis B.
Only one patient had chronic alcoholic and one patient autoimmune liver disease. Patients with spontaneous bacterial infection as primary infection site were not included in the analysis. Patients with chronic liver-disease had a higher infection-rate (69% vs 50%, p < 0.000001) and presented more often with septic-shock (15% vs 10%, p = 0.014) as compared to patients without chronic liver-disease. From all patients with chronic liverdisease, only patients infected with chronic hepatitis C had significantly higher risk of in hospital-mortality [OR Infection-rate and sepsis-rate was significantly higher in patients with liver-cirrhosis as compared to patients without livercirrhosis (67% vs 51%, p = 0.000040 and 15% vs 10%, p = 0.046). In patients with liver-cirrhosis the presence of infection significantly increased in hospitalmortality (49% vs 25%, p = 0.0019). Liver-cirrhosis was an independent risk-factor for in hospital-mortality in patients with infection [OR = 1.816 (1.061-3.106), p = 0.029] (Figure 2) . MELD-score was significantly higher in patients with liver-cirrhosis who died in hospital as compared to survivors (MELD-score 28 vs 23, p = 0.012) and significantly more patients with liver-cirrhosis received hemodialysis (15% vs 8%, p = 0.043). In patients with liver-cirrhosis infections with multiresistantbacteria were found in 32% (38/118) of patients. From these 38 patients, 18% were infected with ESBLproducing bacteria enterobacteriaceae, 18% with MRSA and 55% with VRE.
No significant difference was found for diagnosticaccuracy of MELD-score (AUROC 73%, 95%CI: 65%-82%) and SAPS-II-score (AUROC 72%, 95%CI: 63%-81%) at admission in identifying risk of inhospital-mortality (p > 0.20).
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DISCUSSION
In the present study the infection-rate of patients on the Internal Intensive Care Unit was 53%. Patients with infection had more often comorbid conditions and higher SAPS II scores on admission and during the first seven days of ICU treatment. The results of the present study are in accordance with a 1-d point international multicenter prevalence study by Vincent et al [5] reporting infections in 51% of ICU patients and similar associations. While the present study included Internal Medicine ICU only, the study by Vincent et al. included also surgery and trauma patients. The most common infection focus in the present study was the lung, followed by abdomen, and genitourinary tract infection. This again is in accordance with epidemiological studies concerning infections on ICU [10] [11] [12] . Positive microbiological cultures were obtained in 65% of infected patients with more grampositive than gram-negative microorganisms. This is in accordance with previous studies that reported an increasing incidence of gram-positive microorganisms on ICUs [2] . In hospital-mortality was significantly higher in patients with infections and patients with sepsis as compared to patients without. This again supports results of previous studies [2, 5] . Studies have reported higher hospital-mortality in patients with blood stream infections that receive inappropriate initial antimicrobial-therapy [13] [14] [15] .
In 2006 Kumar et al [16] reported, that effective antimicrobial administration within the first hour of documented hypotension was associated with increased survival to hospital-discharge in patients with septic-shock. However, only 50% of septic-shock patients received effective antimicrobial-therapy within 6 h of documented hypotension [16] . In 2004, the Surviving-Sepsis-Campaign developed guidelines for the management of severe sepsis and septicshock [17] . This included besides others, early cultures for microbial evaluation and "early-goal-directed therapy" with initiation of antimicrobial-therapy as soon as possible [17, 18] . After implementation of the "sepsis-bundle" the Surviving-Sepsis-Campaign study group published a study performed at 165 sites with 15022 subjects and reported an increase in compliance with the sepsis bundle from 11 to 31% two years after implementation and a reduction in mortality [19] . Other studies have reported a similar association [20] . The present study also started after implementation of the sepsis-bundle with early-goaldirected antimicrobial-therapy with empiric calculated therapy on the ICU-ward. Only 9% of patients with infection and 13.5% of patients with septic-shock received inappropriate antimicrobial-therapy. This was lower than reported in a study of Kumar et al [16] published in 2009 including 5715 patients with septicshock with 20% of inappropriate therapy of patients with septic-shock and significant reduction of survival in those receiving inappropriate therapy (10% vs 52%) [16] . Although these two studies cannot be directly compared, it shows a trend towards improvement of initial antimicrobial-therapy. While in the study of Kumar [16] a significant reduction of survival (42%) was found in patients receiving inappropriate antimicrobialtherapy as compared to patients receiving appropriate antimicrobial-therapy, no significant reduction was found in the present study (10%). Antimicrobialtherapy is only one aspect of the sepsis bundle, therefore other factors might have also played a role in the present study. Multiresistant-microorganisms are an increasing burden on ICUs worldwide [21] . Also in the present study multiresistant-bacteria were detected in 23% of patients with infection. This is higher than the overall prevalence in German hospitals [22, 23] . A reason might be the high proportion of patients colonized with such bacteria which arrive from countries with high prevalence of multiresistant-bacteria to be treated at Frankfurt-University-hospital due to its close location to Frankfurt international-airport. Therefore, successful infection control measurements are strictly implemented inhibiting transmission of such pathogens from patient to patient. In addition, Frankfurt-UniversityHospital is a referral-hospital and therefore many severely ill patients, who received multiple antibioticregimens prior to referral, receive further treatment here.
Nevertheless, inappropriate therapy was significantly associated with the presence of multiresistant-bacteria in the present study, suggesting that empirical therapy has to cover multiresistant-bacteria more regularly. Studies have shown that inappropriate antimicrobialtherapy for gram negative ESBL producers was associated with significant increase in mortality (59.5% vs 18.5%, p < 0.001) [24] . Liver cirrhosis and infection 1 citizenship [9, 25] . Also in the present study prior antimicrobial-therapy was an independent risk-factor for infection.
Since the University-Hospital is a liver transplantation center, a high number of patients with liverdisease are treated here. Chronic liver-disease was present in 14% of patients admitted to the ICU with liver-cirrhosis in 64% of these patients. Patients with liver-cirrhosis had a significantly higher infectionrate than patients without liver-cirrhosis. This is in accordance with previous studies reporting infectionrates of 32%-34% in liver-cirrhosis as compared to 5%-7% in the general hospitalized population [26, 27] . A meta-analysis reported a 4-fold increase in mortality in patients with liver-cirrhosis that acquire an infection [6] . In addition, patients with sepsis and liver-cirrhosis have a significant higher mortality-rate as compared to patients with sepsis in the general hospitalized population [27] , this was supported by the results of the present study. The presence of liver-cirrhosis was an independent risk factor for in hospital-mortality in patients with infection. In addition, also in patients with liver-cirrhosis infection with multiresistantbacteria is increasing. A recent study resported an incidence of 39% multiresistant-bacteria in patients with liver-cirrhosis and nosocomial infection [28] . In the present study an infection with multiresistant-bacteria could be found in 32% of patients with liver-cirrhosis. Inappropriate antimicrobial-therapy was significantly more often in patients with liver-cirrhosis. The high rate of multiresistant-bacteria could be an explanation herefore. A recent study revealed a significantly higher rate of septic-shock and in-hospital-mortality in patients with liver-cirrhosis infected with multiresistantbacteria (26% vs 10% and 25% vs 12%) [29] . MELD-score and SAPS-II-score at admission performed equally good concerning the prediction of in-hospital-mortality with diagnostic accuracies of 73% and 72%. A previous systematic review including 21 studies reported diagnostic accuracies of 81% for MELD-score and 83% for SOFA (sequential-organfailure-assessment)-score [29] . Therefore both studies report comparable results for general ICU prognosticmarkers and liver-specific prognostic-markers for patients with liver-cirrhosis on ICU and therefore might supplement each other.
A limitation of the present study is its monocentric retrospective study-design. Nevertheless, the distribution of infections was comparable to previous multicenterstudies [5] . The inclusion of patients with culture-negative infection might be criticized and lead to bias. However, no difference in percentage of appropriate to inappropriate antimicrobial-therapy was found in a subanalysis of patients with culture-positive infections only.
In conclusion, the results of the present study report the successful implementation of early-goaldirected therapy. Increasing burden are multiresistantbacteria, which are associated with increased mortality.
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